CXL-1427

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CXL-1427, covering 2017-01-23 to 2019-05-20. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure [Phase 2]

See pricing